Evidence map›Paper›PMID 33343577›Full record

Trial reportFrontiers in immunology2020

Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis.

Jing Yang, Jiayou Zhang, Renfeng Fan, Wei Zhao, Tian Han, Kai Duan, Xinguo Li, Peiyu Zeng, Jinglong Deng, Jikai Zhang and 1 more

Open access · goldAbstract readClinical Trial, Phase IIIEquivalence Trial
In one paragraph

Trial report in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jing YangNational Institute of Engineering Technology Research in Combination Vaccine, Wuhan, China.
Jiayou ZhangNational Institute of Engineering Technology Research in Combination Vaccine, Wuhan, China.
Renfeng FanGuangdong Province Institute of Biological Products and Materia Medica, Guangzhou, China.
Wei ZhaoNational Institute of Engineering Technology Research in Combination Vaccine, Wuhan, China.
Tian HanNational Institute of Engineering Technology Research in Combination Vaccine, Wuhan, China.
Kai DuanNational Institute of Engineering Technology Research in Combination Vaccine, Wuhan, China.
Xinguo LiNational Institute of Engineering Technology Research in Combination Vaccine, Wuhan, China.
Peiyu ZengGaozhou Center for Disease Control and Prevention, Maoming City, China.
Jinglong DengGaozhou Center for Disease Control and Prevention, Maoming City, China.
Jikai ZhangGuangdong Province Institute of Biological Products and Materia Medica, Guangzhou, China.
Xiaoming YangNational Institute of Engineering Technology Research in Combination Vaccine, Wuhan, China.
Wuhan Institute of Bioengineering · CNNational Vaccine and Serum Institute · CNGuangdong Institute of Biological Products and Drugs · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insights into the potential candidate hub genes may facilitate the generation of safe and effective immunity against seasonal influenza as well as the development of personalized influenza vaccines for the elderly at high risk of influenza virus infection. This study aimed to identify the potential hub genes related to the immune induction process of the 2018/19 seasonal quadrivalent inactivated influenza vaccines (QIVs) in the elderly ≥60 years by using weighted gene co-expression network analysis (WGCNA). From 63 whole blood samples from16 elderly individuals, a total of 13,345 genes were obtained and divided into eight co-expression modules, with two modules being significantly correlated with vaccine-induced immune responses. After functional enrichment analysis, genes under GO terms of vaccine-associated immunity were used to construct the sub-network for identification and functional validation of hub genes.

Indexed as

Gene Regulatory NetworksTranscriptomeAgedAged, 80 and overAge FactorsAntibodies, ViralBiomarkersChinaCytokinesDouble-Blind MethodFemaleGene Expression RegulationHumansImmunity, HumoralImmunogenicity, VaccineInfluenza, HumanAntibodies, ViralBiomarkersCytokinesInfluenza VaccinesMCEMP1 protein, humanMembrane ProteinsOsteonectinSPARC protein, humanhub genesMCEMP1quadrivalent inactivated influenza vaccines (QIVs)reactogenicitySPARCweighted gene co-expression network analysis (WGCNA)

Identifiers

PMID33343577
PMCPMC7746648
OpenAlexW3109111988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.